Addex Research Development from 2010 to 2026
| ADXN Stock | USD 7.70 0.03 0.39% |
Research Development | First Reported 2012-09-30 | Previous Quarter 68.5 K | Current Value 85.3 K | Quarterly Volatility 1.7 M |
Check Addex Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Addex Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 222.4 K, Interest Expense of 3 K or Total Revenue of 345.5 K, as well as many indicators such as Price To Sales Ratio of 14.95, Dividend Yield of 0.0 or PTB Ratio of 0.5. Addex financial statements analysis is a perfect complement when working with Addex Therapeutics Valuation or Volatility modules.
Addex | Research Development | Build AI portfolio with Addex Stock |
Evaluating Addex Therapeutics's Research Development across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Addex Therapeutics's fundamental strength.
Latest Addex Therapeutics' Research Development Growth Pattern
Below is the plot of the Research Development of Addex Therapeutics over the last few years. It is Addex Therapeutics' Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Addex Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Addex Research Development Regression Statistics
| Arithmetic Mean | 4,024,783 | |
| Geometric Mean | 1,951,612 | |
| Coefficient Of Variation | 104.94 | |
| Mean Deviation | 3,627,961 | |
| Median | 2,220,131 | |
| Standard Deviation | 4,223,496 | |
| Sample Variance | 17.8T | |
| Range | 12.2M | |
| R-Value | (0.15) | |
| Mean Square Error | 18.6T | |
| R-Squared | 0.02 | |
| Significance | 0.56 | |
| Slope | (127,690) | |
| Total Sum of Squares | 285.4T |
Addex Research Development History
About Addex Therapeutics Financial Statements
Addex Therapeutics investors utilize fundamental indicators, such as Research Development, to predict how Addex Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Research Development | 391.7 K | 372.1 K |
Pair Trading with Addex Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Addex Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Addex Stock
| 0.67 | DSGN | Design Therapeutics | PairCorr |
| 0.49 | ALT | Altimmune | PairCorr |
| 0.48 | ENGN | enGene Holdings Common | PairCorr |
| 0.44 | KYTX | Kyverna Therapeutics | PairCorr |
| 0.42 | IMMP | Immutep Ltd ADR | PairCorr |
The ability to find closely correlated positions to Addex Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Addex Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Addex Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Addex Therapeutics to buy it.
The correlation of Addex Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Addex Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Addex Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Addex Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Addex Therapeutics Correlation against competitors. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Will Biotechnology sector continue expanding? Could Addex diversify its offerings? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Addex Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (9.19) | Revenue Per Share | Quarterly Revenue Growth (0.15) | Return On Assets | Return On Equity |
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Addex Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Addex Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Addex Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.